Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | GABRA1 | P14867 | 8/20 | 0.76 |
| ▸ | GABRG2 | P18507 | 8/20 | 0.76 |
| ▸ | GABRB3 | P28472 | 8/20 | 0.76 |
| ▸ | GABRA5 | P31644 | 8/20 | 0.76 |
| ▸ | GABRA3 | P34903 | 8/20 | 0.76 |
| ▸ | GABRA2 | P47869 | 7/20 | 0.74 |
| ▸ | GABRB2 | P47870 | 5/20 | 0.74 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.74 |
| ▸ | CCKBR | P32239 | 2/20 | 0.74 |
| ▸ | MC3R | P41968 | 1/20 | 0.74 |
| ▸ | GHSR | Q92847 | 1/20 | 0.74 |
| ▸ | GABRP | O00591 | 1/20 | 0.67 |
| ▸ | GABRD | O14764 | 1/20 | 0.67 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.67 |
| ▸ | ALB | P02768 | 1/20 | 0.67 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.67 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.67 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.67 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nimetazepam SCHEMBL29374297 | 1.00 | LMNA (1.00) | LMNAGABRA1GABRG2GABRB3GABRA5 | |
| Nimetazepam SCHEMBL10689471 | 0.98 | LMNA (0.95) | LMNAGABRA1GABRG2GABRB3GABRA5 | |
| Nimetazepam SCHEMBL9542099 | 0.98 | LMNA (0.95) | LMNAGABRA1GABRG2GABRB3GABRA5 | |
| Nimetazepam SCHEMBL1003526 | 0.90 | LMNA (0.81) | LMNAGABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL18319288 | 0.88 | LMNA (0.79) | LMNAGABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL5044330 | 0.88 | LMNA (0.78) | LMNAGABRA1GABRG2GABRB3GABRA5 | |
| Flunitrazepam SCHEMBL1900353 | 0.87 | GABRA1 (0.80) | LMNAGABRA1GABRG2GABRB3GABRA5 | |
| Flunitrazepam SCHEMBL8812488 | 0.85 | GABRA1 (1.00) | LMNAGABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL9473650 | 0.85 | GABRA1 (0.78) | LMNAGABRA1GABRG2GABRB3GABRA5 | |
| Flunitrazepam SCHEMBL44169 | 0.85 | GABRA1 (1.00) | LMNAGABRA1GABRG2GABRB3GABRA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3953 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260076953-A1 | METHODS OF DIAGNOSING AND TREATING ADHD IN BIOMARKER POSITIVE SUBJECTS | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2026-03-19 | — | — | US | claimed |
| EP-3507371-B1 | COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM | UNIV RUTGERS (US) | 2026-01-28 | — | — | EP | claimed |
| US-20250375421-A1 | METHODS OF USING DMT | SHULMAN WILLIAM (US) | 2025-12-11 | — | — | US | claimed |
| US-12396981-B2 | Methods of using DMT | SHULMAN WILLIAM (US) | 2025-08-26 | — | — | US | claimed |
| US-12350379-B2 | Extended release pharmaceutical formulation and methods of treatment | DOUGLAS PHARMACETICALS LTD (NZ) | 2025-07-08 | — | — | US | claimed |
| US-20250120962-A1 | NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ATTENTION DEFICIT DISORDER AND 22Q SYNDROME | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2025-04-17 | — | — | US | claimed |
| EP-3518975-B1 | FORMULATION COMPRISING FENFLURAMINE AND CANNABIDIOL AND ITS USE IN THE TREATMENT OF SEIZURES | ZOGENIX INTERNATIONAL LTD (GB) | 2025-04-09 | — | — | EP | claimed |
| EP-4023222-B1 | NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATOR FOR TREATMENT OF 22Q SYNDROME | CHILDRENS HOSPITAL PHILADELPHIA (US) | 2024-12-18 | — | — | EP | claimed |
| US-12133922-B2 | Abuse resistant capsule | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2024-11-05 | — | — | US | claimed |
| US-20240307386-A1 | NOVEL METHODS | INTRA-CELLULAR THERAPIES, INC. | 2024-09-19 | — | — | US | claimed |
| EP-0233276-A4 | WRAPPING. | CROWELL CORP (US) | 1988-12-15 | — | — | EP | claimed |
| EP-0281324-A2 | Improved passivation for integrated circuit structures | ADVANCED MICRO DEVICES, INC. (US) | 1988-09-07 | — | — | EP | claimed |
| US-4721709-A | Novel pharmaceutical compositions containing hydrophobic practically water-insoluble drugs adsorbed on pharmaceutical excipients as carrier; process for their preparation and the use of said compositions | PYARE SETH (CH) | 1988-01-26 | — | — | US | claimed |
| EP-0233276-A1 | WRAPPING. | CROWELL CORP (US) | 1987-08-26 | — | — | EP | claimed |
| WO-1987001092-A1 | WRAPPING | THE CROWELL CORPORATION (US) | 1987-02-26 | — | — | WO | claimed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | claimed |
| EP-0153939-A1 | VACCINE AND ANTIGEN AGAINST PALUDISM AND PREPARATION PROCESS THEREOF | INSTITUT MERIEUX (FR) | 1985-09-11 | — | — | EP | claimed |
| WO-1985000977-A1 | VACCINE AND ANTIGEN AGAINST PALUDISM AND PREPARATION PROCESS THEREOF | INSTITUT MERIEUX S.A. (FR) | 1985-03-14 | — | — | WO | claimed |
| EP-0010899-B1 | PROCESS FOR CONCENTRATING DILUTE SULPHURIC ACID IN AN EVAPORATOR | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1983-02-02 | — | — | EP | claimed |
| US-4044003-A | Process for preparing 1,4-benzodiazepines | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-08-23 | — | — | US | claimed |